Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : VPM1002
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : FGK Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : VPM1002 is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Respiratory Tract Infections.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
June 17, 2020
Lead Product(s) : VPM1002
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : FGK Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : VPM1002
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : FGK Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic
Details : VPM1002 is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Respiratory Tract Infections.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
May 13, 2020
Lead Product(s) : VPM1002
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : FGK Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : VPM1002
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Recipient : Serum Institute of India
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : VPM1002 is a Vaccine drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Tuberculosis.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
April 17, 2020
Lead Product(s) : VPM1002
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Recipient : Serum Institute of India
Deal Size : Inapplicable
Deal Type : Inapplicable